Ulf Persson

4.6k total citations
163 papers, 3.3k citations indexed

About

Ulf Persson is a scholar working on Economics and Econometrics, Surgery and Oncology. According to data from OpenAlex, Ulf Persson has authored 163 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Economics and Econometrics, 18 papers in Surgery and 17 papers in Oncology. Recurrent topics in Ulf Persson's work include Health Systems, Economic Evaluations, Quality of Life (58 papers), Pharmaceutical Economics and Policy (17 papers) and Pharmaceutical studies and practices (13 papers). Ulf Persson is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (58 papers), Pharmaceutical Economics and Policy (17 papers) and Pharmaceutical studies and practices (13 papers). Ulf Persson collaborates with scholars based in Sweden, France and United Kingdom. Ulf Persson's co-authors include Ola Ghatnekar, Michael Willis, Björn Lindgren, Stefan Jendteg, Jenny M. Norlin, Knut Ödegaard, Katarina Steen Carlsson, Jan Larsson, Jan Apelqvist and Marcus Schmitt‐Egenolf and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Ulf Persson

161 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Persson Sweden 34 1.1k 496 342 322 322 163 3.3k
Marta Soares United Kingdom 31 926 0.9× 791 1.6× 496 1.5× 187 0.6× 181 0.6× 94 3.0k
Min‐Woong Sohn United States 30 410 0.4× 713 1.4× 560 1.6× 773 2.4× 380 1.2× 88 3.5k
Till Uhlig Norway 45 338 0.3× 918 1.9× 261 0.8× 143 0.4× 297 0.9× 205 7.0k
Michael Soljak United Kingdom 27 400 0.4× 255 0.5× 714 2.1× 194 0.6× 423 1.3× 72 2.3k
Danny Ruta United Kingdom 32 1.0k 1.0× 949 1.9× 957 2.8× 414 1.3× 472 1.5× 64 5.1k
Dawn Craig United Kingdom 26 250 0.2× 729 1.5× 382 1.1× 460 1.4× 754 2.3× 131 3.1k
Michael Clark United Kingdom 30 446 0.4× 815 1.6× 244 0.7× 658 2.0× 345 1.1× 71 3.1k
Tracy Merlin Australia 26 419 0.4× 573 1.2× 499 1.5× 117 0.4× 158 0.5× 86 2.4k
James W. Shaw United States 27 1.4k 1.4× 464 0.9× 842 2.5× 114 0.4× 313 1.0× 92 3.6k
Jonathan D. Campbell United States 32 600 0.6× 360 0.7× 295 0.9× 160 0.5× 419 1.3× 121 4.1k

Countries citing papers authored by Ulf Persson

Since Specialization
Citations

This map shows the geographic impact of Ulf Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Persson more than expected).

Fields of papers citing papers by Ulf Persson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Persson. The network helps show where Ulf Persson may publish in the future.

Co-authorship network of co-authors of Ulf Persson

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Persson. A scholar is included among the top collaborators of Ulf Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Persson. Ulf Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drummond, Michael, Omar Dabbous, Mondher Toumi, et al.. (2024). Real-world evidence for coverage determination of treatments for rare diseases. Orphanet Journal of Rare Diseases. 19(1). 47–47. 6 indexed citations
2.
Vonck, Kristl, Arnaud Biraben, Magdalena Bosak, et al.. (2023). Usage and impact of patient‐reported outcomes in epilepsy. Brain and Behavior. 13(12). e3342–e3342. 3 indexed citations
3.
Norlin, Jenny M., Ulf Persson, Daniel Oudin Åström, et al.. (2022). Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health‐Related Quality of Life. Movement Disorders Clinical Practice. 10(3). 392–398. 3 indexed citations
4.
Tarricone, Rosanna, Oriana Ciani, Aleksandra Torbica, et al.. (2020). Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective. Expert Review of Medical Devices. 17(10). 993–1006. 24 indexed citations
5.
Persson, Ulf, et al.. (2020). The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development. PharmacoEconomics - Open. 5(1). 77–88. 3 indexed citations
6.
Persson, Ulf, et al.. (2016). Betalningsviljan för att minska risken för icke-dödliga och dödliga skador i samband med vägtrafikolyckor – en studie med kedje-ansats. RePEc: Research Papers in Economics. 2 indexed citations
7.
Péntek, Márta, László Gulàcsi, Valentin Brodszky, et al.. (2016). Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe. The European Journal of Health Economics. 17(S1). 89–98. 40 indexed citations
8.
Cavazza, Marianna, Yllka Kodra, Patrizio Armeni, et al.. (2016). Social/economic costs and quality of life in patients with haemophilia in Europe. The European Journal of Health Economics. 17(S1). 53–65. 55 indexed citations
9.
López‐Bastida, Julio, Renata Linertová, Juan Oliva, et al.. (2016). Social/economic costs and health-related quality of life in patients with scleroderma in Europe. The European Journal of Health Economics. 17(S1). 109–117. 30 indexed citations
10.
Persson, Ulf, et al.. (2013). Costs and Utilities of Manual Therapy and Orthopedic Standard Care for Low-prioritized Orthopedic Outpatients of Working Age. Clinical Journal of Pain. 30(8). 730–736. 13 indexed citations
11.
Schlander, Michael, Silvio Garattini, Peter L. Kolominsky‐Rabas, et al.. (2013). Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders. Value in Health. 16(7). A324–A324. 4 indexed citations
12.
Persson, Ulf, Johanna Svensson, & Billie Pettersson. (2012). A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing. Applied Health Economics and Health Policy. 10(4). 217–225. 18 indexed citations
13.
14.
Persson, Ulf, Michael Willis, & Knut Ödegaard. (2009). A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden. The European Journal of Health Economics. 11(2). 195–203. 37 indexed citations
15.
Hjelmgren, Jonas, et al.. (2008). Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden. Scandinavian Journal of Infectious Diseases. 40(9). 721–729. 27 indexed citations
16.
Glenngård, Anna & Ulf Persson. (2006). En blodtransfusion i Sverige - så mycket kostar den samhället. Läkartidningen. 103(38). 6–2752. 1 indexed citations
17.
Hagell, Peter, et al.. (2002). Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Movement Disorders. 17(6). 1213–1220. 97 indexed citations
18.
Persson, Ulf & Knut Ödegaard. (1995). External Cost Estimates of Road Traffic Accidents: An International Comparison. Journal of transport economics and policy. 29(3). 291–304. 23 indexed citations
19.
Roos, Kristian, et al.. (1995). The economic cost of a streptococcal tonsillitis episode. Scandinavian Journal of Primary Health Care. 13(4). 257–260. 21 indexed citations
20.
Friman, L., Rolf Udén, S Ewerth, G Hellers, & Ulf Persson. (1978). ERCP and pharmacoangiography in diagnosis of pancreatic disease. A comparative study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 482. 13–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Soares Breakdown of academic impact, for papers by Min‐Woong Sohn Breakdown of academic impact, for papers by Till Uhlig Breakdown of academic impact, for papers by Michael Soljak Breakdown of academic impact, for papers by Danny Ruta Breakdown of academic impact, for papers by Dawn Craig Breakdown of academic impact, for papers by Michael Clark Breakdown of academic impact, for papers by Tracy Merlin Breakdown of academic impact, for papers by James W. Shaw Breakdown of academic impact, for papers by Jonathan D. Campbell
Rankless by CCL
2026